MXL INVESTIGATION NEWS: MaxLinear, Inc. (NASDAQ:MXL) is

NEW YORK, July 27, 2024 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation of MaxLinear, Inc. (NASDAQ: MXL) for possible violations of the federal securities laws.

If you have invested in MaxLinear, you can get more information at: https://www.bfalaw.com/cases-investigations/maxlinear-inc.

Why did MaxLinear’s share price fall?

MaxLinear offers integrated high frequency analog and mixed-signal semiconductor products for broadband communications applications.

After the market closed on July 24, 2024, MaxLinear reported second quarter 2024 results. Net revenue for the quarter was only $92 million, down 50% year over year. The company attributed the decline, at least in part, to the ongoing reduction of excess customer inventory, which resulted in weaker demand.

The news caused a steep decline in MaxLinear stock price. The company’s stock price closed at $22.29 per share on July 24, 2024. Before the market open on July 25, 2024, MaxLinear stock price was in the range of $16.40 per share, a decline of $5.89 per share, or 26%.

Click here for more info: https://www.bfalaw.com/cases-investigations/maxlinear-inc.

What can you do?

If you have invested in MaxLinear, Inc., you may have legal options. We encourage you to provide your information to the firm. All representations are made on a contingency basis, with no costs to you. Shareholders are not responsible for court or litigation costs. The firm will seek court approval for any fees and costs.

Send your information to:

https://www.bfalaw.com/cases-investigations/maxlinear-inc

Or contact us:
Ross Shikowitz
[email protected]
212-789-3619

Why Bleichmar Fonti & Auld LLP?

Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in class actions and shareholder litigation. It was named a Top 5 Plaintiffs Firm for 2023 by ISS SCAS and its lawyers have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Recent notable successes include BFA recovering over $900 million in value from the board of Tesla, Inc. (subject to court approval) and $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, visit https://www.bfalaw.com.

https://www.bfalaw.com/cases-investigations/maxlinear-inc

Attorney advertising. Past results do not guarantee future results.